CoChat

Effect of Including Important Clinical Variables on Accuracy of the Lung Allocation Score for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Lehr, Carli J., Skeans, Melissa, Dasenbrook, Elliott, Fink, Aliza, Fernandez, Gabriela, Faro, Albert, Valapour, Maryam · 2019 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Rationale: Clinical variables associated with shortened survival in patients with advanced-stage cystic fibrosis (CF) are not included in the lung allocation score (LAS). Objectives: To identify variables associated with wait-list and post-transplant mortality for CF lung transplant candidates using a novel database and to analyze the impact of including new CF-specific variables in the LAS system. Methods: A deterministic matching algorithm identified patients from the Scientific Registry of Transplant Recipients and the Cystic Fibrosis Foundation Patient Registry. LAS wait-list and post-transplant survival models were recalculated using CF-specific variables. This multicenter, retrospective, population-based study of all lung transplant wait-list candidates aged 12 years or older from January 1, 2011, to December 31, 2014, included 9,043 patients on the lung transplant waiting list and 6,110 lung transplant recipients between 2011 and 2014, comprising 1,020 and 677 with CF, respectively. Measurements and Main Results: Measured outcomes were changes in LAS and lung allocation rank. For CF candidates, any Burkholderia sp. (hazard ratio [HR], 2.8; 95% confidence interval [CI], 1.2–6.6), 29–42 days hospitalized (HR 2.8; CI 1.3–5.9), massive hemoptysis (HR 2.1; CI 1.1–3.9), and relative drop in FEV1 ≥30% over 12 months (HR 1.7; CI 1.0–2.8) increased wait-list mortality risk; pulmonary exacerbation time 15–28 days (1.8; 1.1–2.9) increased post-transplant mortality risk. A relative drop in FEV1 ≥10% in chronic obstructive pulmonary disease (COPD) candidates was associated with increased wait-list mortality risk (HR 2.6; CI 1.2–5.4). Variability in LAS score and rank increased in patients with CF. Priority for transplant increased for COPD candidates. Access did not change for other diagnosis groups. Conclusions: Adding CF-specific variables improved discrimination among wait-listed CF candidates and benefited COPD candidates.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201902-0252oc

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. Dasenbrook, 2017, Addition of FEV1 drop to LAS may improve access of CF patients to transplant: analysis of the SRTR and US CF Foundation patient registries [abstract], Am J Transplant, 17, 262
  2. Dasenbrook, 2016, Description of a novel database: merging the US CF Patient Registry with the Scientific Registry of Transplant Recipients [abstract], Pediatr Pulmonol, 51, 377
  3. Traver, 1979, Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study, Am Rev Respir Dis, 119, 895

Cited by

See all 36

Metadata

Authors
Lehr, C. J., Skeans, M., Dasenbrook, E., Fink, A., Fernandez, G., Faro, A., & Valapour, M.
Affiliations
  • Cleveland Clinic (US)
  • Hennepin Healthcare Research Institute (US)
  • Cystic Fibrosis Foundation (US)
Corresponding author
Valapour, Maryam
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2019-10
Volume
200
Issue
8
Pages
1013-1021
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2950878989
Cited by
35
References
27
Citations by year
2025: 2 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 4 · 2020: 4 · 2019: 4
FWCI
5.06
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cystic Fibrosis Foundation
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
Keywords
lung allocation score, cystic fibrosis, chronic obstructive pulmonary disease, lung transplantation, post-transplant mortality, Burkholderia, pulmonary exacerbations, FEV1 decline, transplant prioritization, clinical risk factors
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Algorithms, Child, Cystic Fibrosis, Female, Humans, Male, Middle Aged, Tissue and Organ Procurement, Retrospective Studies, Severity of Illness Index, Waiting Lists, Reproducibility of Results, Proportional Hazards Models, Lung Transplantation, Practice Guidelines as Topic, Patient Selection, Pulmonary Disease, Chronic Obstructive, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.